Avalanche Hit With Stock Drop Suit Over Eye Drug Study
Avalanche Biotechnologies Inc. was sued in California federal court Thursday for allegedly misleading shareholders about a clinical trial's design, to inflate the share price before and after the vision treatment developer's...To view the full article, register now.
Already a subscriber? Click here to view full article